Abstract:A CRISPR‐Cas12a‐based dual‐mode assay strategy is developed for multiplexed nucleic acid detection by incorporating precise querying and approximate pattern matching. With the assay, HPV16 and HPV18 are not only distinguished but also 12 other high‐risk pooled HPV subtypes are detected. The assay into a paper‐based microfluidic chip is integrated and its clinical utility with 75 clinical samples, demonstrating significant promise for simple, sensitive, specific, and multiplexed detection of pathogens at the point of care is validated. CRISPR‐Cas12a works like a sophisticated algorithm in nucleic acid detection, yet its challenge lies in sometimes failing to distinguish targets with mismatches due to its specificity limitations. Here, the mismatch profiles, including the quantity, location, and type of mismatches in the CRISPR‐Cas12a reaction, are investigated and its various tolerances to mismatches are discovered. By harnessing the specificity defect of the CRISPR‐Cas12a enzyme, a dual‐mode detection strategy is designed, which includes approximate matching and precise querying of target sequences and develop a programmable multiplexed nucleic acid assay. With the assay, 14 high‐risk human papillomavirus (HPV) subtypes are simultaneously detected, collectively responsible for 99% of cervical cancer cases, with attomolar sensitivity. Specifically, the assay not only distinguishes HPV16 and HPV18, the two most common subtypes but also detects 12 other high‐risk pooled HPV subtypes. To enable low‐cost point‐of‐care testing, the assay is incorporated into a paper‐based microfluidic chip. Furthermore, the clinical performance of the paper‐based microfluidic chip is validated by testing 75 clinical swab samples, achieving performance comparable to that of PCR. This programmable multiplexed nucleic acid assay has the potential to be widely applied for sensitive, specific, and simultaneous detection of different pathogens.

A Triple-Mismatch Differentiating assay exploiting activation and trans cleavage of CRISPR-Cas12a for mutation detection with ultra specificity and sensitivity

An Ultra-Sensitive CRISPR-Cas12a and Aptamer-Based Biosensor Utilizing Entropy-driven Catalytic DNA Networks for Precise Detection of DNA Methyltransferase 1

Efficient, specific and direct detection of double-stranded DNA targets using Cas12f1 nucleases and engineered guide RNAs

A universal and sensitive gene mutation detection method based on CRISPR-Cas12a

Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA

A superior strategy for single-cell mutational screening via multiplex-targeted QPCR using the BioMark HD microfluidic platform.

Detection of Mitochondrial Mutations Through Isothermal Nucleic Acid Amplification Coupled With Clustered Regularly Interspaced Short Palindromic Repeat-Associated Endonuclease Cas13a

T-shaped Probe System with Low Detection Limits, Versatility and Low Cost for Multiple Mutation Detection

A Protospacer Adjacent Motif-Free, Multiplexed, and Quantitative Nucleic Acid Detection Platform with Barcode-Based Cas12a Activity

Gene point mutation information translation and detection: Leveraging single base extension and CRISPR/Cas12a

Hairpin-locker mediated CRISPR/Cas tandem system for ultrasensitive detection of DNA without pre-amplification

A PAM-free CRISPR/Cas12a ultra-specific activation mode based on toehold-mediated strand displacement and branch migration

Programmable Multiplexed Nucleic Acid Detection by Harnessing Specificity Defect of CRISPR‐Cas12a

One-Pot Endonucleolytically Exponentiated Rolling Circle Amplification by CRISPR-Cas12a Affords Sensitive, Expedited Isothermal Detection of MicroRNAs

Temperature-boosted PAM-less activation of CRISPR-Cas12a combined with selective inhibitors enhances detection of SNVs with VAFs below 0.01%

Single-molecule detection of cancer mutations using a novel PCR-LDR-qPCR assay

In Situ Hand-in-hand DNA Tile Assembly and CRISPR/Cas12a-based Ultrasensitive Detection for Leukemia Diagnosis

Cas12a-based direct visualization of nanoparticle-stabilized fluorescence signal for multiplex detection of DNA methylation biomarkers

High-Fidelity Identification of Single Nucleotide Polymorphism by Type V CRISPR Systems

CRISPR/Cas12a Bio-Assay Integrated with Metal-Organic Framework Based Enhanced Fluorescent Labels for Ultrasensitive Detection of Circulating Tumor DNA

A multi-AS-PCR-coupled CRISPR/Cas12a assay for the detection of ten single-base mutations